-+ 0.00%
-+ 0.00%
-+ 0.00%

Aptahem hosts “Way Forward for Apta-1” webinar, replay now available

PUBT·09/30/2026 14:14:38
Listen to the news
Aptahem hosts “Way Forward for Apta-1” webinar, replay now available
  • Aptahem hosted a webinar on Sept. 28, 2026 outlining its clinical development strategy for lead candidate Apta-1.
  • CEO Mikael Lindstam also discussed ongoing partnership efforts alongside the company’s ongoing rights issue of units.
  • Apta-1 remains in early-stage clinical development, targeting acute, life-threatening conditions involving coagulation, inflammation, and tissue damage.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptahem AB published the original content used to generate this news brief via Cision (Ref. ID: 202609301013BITN____UKPR__SV_20260930-BIT-7509-0) on September 30, 2026, and is solely responsible for the information contained therein.